HK1036753A1 - Polymer compositions for use in therapy - Google Patents

Polymer compositions for use in therapy

Info

Publication number
HK1036753A1
HK1036753A1 HK01107241A HK01107241A HK1036753A1 HK 1036753 A1 HK1036753 A1 HK 1036753A1 HK 01107241 A HK01107241 A HK 01107241A HK 01107241 A HK01107241 A HK 01107241A HK 1036753 A1 HK1036753 A1 HK 1036753A1
Authority
HK
Hong Kong
Prior art keywords
therapy
polymer compositions
phosphate
polymers
compositions
Prior art date
Application number
HK01107241A
Other languages
English (en)
Inventor
Stephen Randall Holmes-Farley
Harry W Mandeville Iii
George Mcclelland Whitesides
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26802726&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1036753(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of HK1036753A1 publication Critical patent/HK1036753A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
HK01107241A 1993-08-11 1998-08-11 Polymer compositions for use in therapy HK1036753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10559193A 1993-08-11 1993-08-11
US08/238,458 US5496545A (en) 1993-08-11 1994-05-05 Phosphate-binding polymers for oral administration
HK98109833A HK1009243A1 (en) 1993-08-11 1998-08-11 Phosphate-binding polymers for oral administration

Publications (1)

Publication Number Publication Date
HK1036753A1 true HK1036753A1 (en) 2002-01-18

Family

ID=26802726

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01107241A HK1036753A1 (en) 1993-08-11 1998-08-11 Polymer compositions for use in therapy
HK98109833A HK1009243A1 (en) 1993-08-11 1998-08-11 Phosphate-binding polymers for oral administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK98109833A HK1009243A1 (en) 1993-08-11 1998-08-11 Phosphate-binding polymers for oral administration

Country Status (16)

Country Link
US (1) US5496545A (xx)
EP (3) EP1676581A3 (xx)
JP (2) JP3113283B2 (xx)
KR (1) KR100346766B1 (xx)
AT (2) ATE204756T1 (xx)
AU (1) AU689797B2 (xx)
CA (3) CA2310960C (xx)
DE (5) DE69434726T2 (xx)
DK (2) DK1133989T3 (xx)
ES (2) ES2161780T3 (xx)
HK (2) HK1036753A1 (xx)
LU (2) LU90884I2 (xx)
NL (2) NL300080I1 (xx)
NZ (1) NZ271826A (xx)
PT (2) PT716606E (xx)
WO (1) WO1995005184A2 (xx)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69410995T2 (de) * 1993-02-17 1998-11-05 British Technology Group Ltd., London 1 guanidino gruppen enthaltende polymere zur verwendung in der therapie
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
GB9503061D0 (en) * 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
EP0793960B1 (en) * 1996-03-05 2001-08-01 Mitsubishi Chemical Corporation Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia
US6180094B1 (en) 1996-07-19 2001-01-30 Nikken Chemicals Co., Ltd. Remedies for hyperphosphatemia
ATE361335T1 (de) * 1996-10-23 2007-05-15 Dow Global Technologies Inc Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat
AU2446497A (en) * 1997-03-25 1998-10-20 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers combined with a calcium supplement for oral administration
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) * 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
WO1999040990A1 (en) * 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
WO1999047587A1 (en) * 1998-03-19 1999-09-23 Geltex Pharmaceuticals, Inc. Continuous crosslinking of polymer gels
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
JP4749649B2 (ja) * 1998-10-12 2011-08-17 中外製薬株式会社 リン酸結合性ポリマー
TW568788B (en) 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
JP4634618B2 (ja) * 1999-04-16 2011-02-16 アボット・ラボラトリーズ 架橋ポリアリルアミン塩酸塩の製造方法
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
US6362266B1 (en) 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
US6180754B1 (en) 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
WO2001025291A1 (en) * 1999-10-07 2001-04-12 University Of Maryland Sugar binding polymers and the use thereof
US20030202958A1 (en) * 1999-10-15 2003-10-30 Strickland Alan D. Dialysis solution including polyglycol osmotic agent
BR0014820A (pt) * 1999-10-15 2002-06-11 Dow Chemical Co Solução de diálise incluindo agente osmótico de poliglicol, e seu uso
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
CN1202812C (zh) * 1999-10-19 2005-05-25 基酶有限公司 直接压缩聚合物片剂核
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US6844372B2 (en) 2000-03-09 2005-01-18 Hisamitsu Pharmaceutical Co., Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
AU2001241076A1 (en) * 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
AU2001241095A1 (en) 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
WO2002032974A2 (en) * 2000-10-18 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Polymer and its use for the treatment and/or prevention of hyperphosphoremia
AU2001292368A1 (en) * 2000-11-28 2002-06-11 Mitsubishi Pharma Corporation Antiobestic agents and health foods
KR100782245B1 (ko) * 2000-11-28 2007-12-05 미쯔비시 웰 파마 가부시키가이샤 축적성 염소함유 화합물의 배설 촉진제
AT409630B (de) * 2000-12-13 2002-09-25 Dsm Fine Chem Austria Gmbh Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
WO2002066543A1 (en) 2001-02-16 2002-08-29 Genzyme Corporation Method of drying a material having a cohesive phase
EP1923064B1 (en) 2001-04-18 2017-06-28 Genzyme Corporation Use of amine polymer for lowering serum glucose
WO2002085378A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Low salt forms of polyallylamine
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
CN1509180A (zh) * 2001-04-18 2004-06-30 ԭ���ø� 用脂肪族聚胺治疗综合症x的方法
DK1392331T3 (da) * 2001-04-18 2008-06-23 Genzyme Corp Anvendelse af colesevelam eller sevelamer, hydrogenchlorid til sænkning af serumglucoseniveauet
MX2008011686A (es) * 2001-05-25 2010-05-27 Marathon Oil Co Inhibicion de sulfuracion del deposito utilizando una inyeccion de agua tratada.
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
JP2003033651A (ja) * 2001-07-24 2003-02-04 Chisso Corp 経口リン吸着剤及びそれを含む食品
DE60223551T2 (de) 2001-07-30 2008-10-23 Mitsubishi Pharma Corp. Mittel zu linderung von hyperglykämie nach dem essen
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
FR2833169B1 (fr) * 2001-12-07 2004-07-16 Oreal Composition filtrante contenant un derive de 1,3,5-triazine, un derive du dibenzoylmethane, et un derive de 2-hydroxybenzophenone aminosubstitue
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
DE60307799T2 (de) * 2002-03-19 2007-08-16 Genzyme Corp., Cambridge Hemmer des phosphattransports
AT411463B (de) 2002-09-03 2004-01-26 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
WO2004037274A1 (en) * 2002-10-22 2004-05-06 Genzyme Corporation Amine polymers for promoting bone formation
AT412473B (de) 2003-01-15 2005-03-25 Dsm Fine Chem Austria Gmbh Verfahren zur kontinuierlichen trocknung von n- bzw. amino-, ammonium- oder spirobicyclische ammoniumgruppen haltigen polymeren
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US8426528B2 (en) * 2004-02-23 2013-04-23 E I Du Pont De Nemours And Company Preparation of crosslinked polymers containing biomass derived materials
WO2005082977A1 (en) * 2004-02-23 2005-09-09 E.I. Dupont De Nemours And Company Crosslinked polymers containing biomass derived materials
JPWO2005092349A1 (ja) 2004-03-26 2008-02-07 田辺三菱製薬株式会社 インスリン抵抗性改善剤
DE602005018619D1 (de) 2004-03-30 2010-02-11 Relypsa Inc Ionenbindende zusammensetzungen
US20050276781A1 (en) * 2004-06-09 2005-12-15 Ross Edward A Molecularly imprinted phosphate binders for therapeutic use
US20060067883A1 (en) * 2004-09-24 2006-03-30 Biosphere Medical, Inc. Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof
JP2008531751A (ja) * 2004-10-13 2008-08-14 イリプサ， インコーポレイテッド 架橋アミンポリマー
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
JP4547620B2 (ja) * 2004-12-02 2010-09-22 日東紡績株式会社 架橋アリルアミン類重合体の製造方法
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
JP2008526771A (ja) * 2004-12-30 2008-07-24 ジェンザイム コーポレーション 高リン酸血症のための亜鉛含有処置
CN101163731A (zh) * 2005-02-23 2008-04-16 纳幕尔杜邦公司 使用α，ω-二官能醛糖二酰胺作为单体和交联剂的方法
JP2008533272A (ja) * 2005-03-16 2008-08-21 ユーエスヴィー リミテッド 架橋ポリアリルアミンポリマーの調製のための改良された方法
RU2377980C2 (ru) * 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
CA2620406A1 (en) * 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
ES2556217T3 (es) * 2005-09-15 2016-01-14 Genzyme Corporation Formulación en bolsa para polímeros de amina
AU2012205214B2 (en) * 2005-09-15 2015-05-21 Genzyme Corporation Formulation for Amine Polymers
DE112006002617T5 (de) 2005-09-30 2008-08-28 Ilypsa Inc., Santa Clara Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite
WO2007041569A1 (en) 2005-09-30 2007-04-12 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
JP2009514966A (ja) * 2005-11-08 2009-04-09 ジェンザイム・コーポレーション 高リン血症のためのマグネシウム含有重合体
WO2007070801A2 (en) * 2005-12-12 2007-06-21 Allaccem, Inc. Methods and systems for preparing antimicrobial films and coatings
ITRM20060204A1 (it) * 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
US20080085259A1 (en) * 2006-05-05 2008-04-10 Huval Chad C Amine condensation polymers as phosphate sequestrants
WO2007145308A1 (ja) 2006-06-16 2007-12-21 Mitsubishi Tanabe Pharma Corporation 糸球体疾患の予防及び/または治療剤
JP2009542653A (ja) * 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
BRPI0715053A2 (pt) * 2006-07-18 2013-03-19 Genzyme Corp composiÇço farmacÊutica, mÉtodo para tratar doenÇas, e, polÍmero
JP5301273B2 (ja) 2006-08-09 2013-09-25 田辺三菱製薬株式会社 錠剤
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2441779A1 (en) * 2006-09-01 2012-04-18 USV Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0716319A8 (pt) 2006-10-25 2019-02-05 Aovatechnologies Inc método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano correndo o risco de desenvolver ou que desenvolveu hiperfosfatomia e método para reduzir os efeitos colaterais da terapia de vitamina d em um ser humano
US8877198B2 (en) 2006-10-26 2014-11-04 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption
JP2010513271A (ja) * 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
JP2008169758A (ja) * 2007-01-11 2008-07-24 Bosch Corp ターボチャージャ駆動制御方法及びその装置
DK2125026T3 (en) 2007-02-21 2014-12-08 Allaccem Inc FORMATIONS BASED ON bridged POLYCYCLIC COMPOUNDS FOR INHIBITION AND RELIEF OF DISEASES
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
US20100196305A1 (en) * 2007-03-08 2010-08-05 Dhal Pradeep K Sulfone polymer compositions
US8034833B2 (en) * 2008-03-20 2011-10-11 Biolink Life Sciences, Inc. Phosphorus binder for treatment of renal disease
EP2152277A1 (en) * 2007-04-27 2010-02-17 Genzyme Corporation Amido-amine dendrimer compositions
WO2009008480A1 (ja) 2007-07-11 2009-01-15 Toray Industries, Inc. 架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途
EP2016947A1 (en) * 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) * 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
JP2011506449A (ja) * 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
WO2009128085A1 (en) * 2008-04-15 2009-10-22 Lupin Limited Process for the preparation of cross-linked polyallylamine polymer
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US8404784B2 (en) * 2008-12-03 2013-03-26 Navinta Llc Manufacturing process of making polymeric amine salts
US20100166861A1 (en) * 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
AU2010209293A1 (en) 2009-01-22 2011-09-08 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
CA2765370A1 (en) 2009-06-16 2010-12-23 Watson Pharma Private Limited Processes for the preparation of sevelamer carbonate
US8673272B2 (en) * 2009-07-27 2014-03-18 Isp Investments Inc. Ultraviolet-absorbing compounds
GB0921951D0 (en) * 2009-12-16 2010-02-03 Fujifilm Mfg Europe Bv Curable compositions and membranes
JP5377265B2 (ja) * 2009-12-16 2013-12-25 一般財団法人川村理化学研究所 ポリマー／酒石酸結晶性ナノ複合体及びその製造方法
ES2414383T5 (es) 2010-01-15 2016-12-12 Graphic Packaging International, Inc. Garra de cadena continua para cajas de cartón octogonales
BR112012021444A2 (pt) 2010-02-24 2016-05-31 Relypsa Inc polímero de amina reticulado, composição farmacêutica, método de redução do colesterol ldl sérico em um indivíduo, métodos para tratar doença, de remoção de sais biliares de um indivíduo, e para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de aminas.
JP5717422B2 (ja) * 2010-11-30 2015-05-13 株式会社パイロットコーポレーション ゲル状組成物の製造方法
IT1404163B1 (it) 2011-02-01 2013-11-15 Chemi Spa Processo per la preparazione di poliallilamine reticolate o loro sali farmaceuticamente accettabili
ES2563316T3 (es) 2011-02-09 2016-03-14 Synthon Bv Formas estabilizadas de envasado de sevelamer
CN102796262B (zh) * 2011-05-24 2014-11-12 北大方正集团有限公司 一种碳酸司维拉姆的制备方法
EP2773329B1 (en) 2011-11-04 2016-01-13 Synthon BV Pharmaceutical compositions comprising sevelamer
US20130123433A1 (en) 2011-11-14 2013-05-16 Formosa Laboratories, Inc. Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
WO2013087238A1 (en) 2011-12-13 2013-06-20 Synthon Bv Preparation of sevelamer with reduced content of allylamine
WO2013087237A1 (en) 2011-12-13 2013-06-20 Synthon Bv Purification of sevelamer and related polyallylamines
CN102675510B (zh) * 2012-05-28 2014-04-02 诚达药业股份有限公司 司维拉姆的合成工艺
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología
WO2014159759A1 (en) 2013-03-13 2014-10-02 Biosphere Medical, Inc. Compositions and associated methods for radioisotope-binding microparticles
CN103446179B (zh) * 2013-05-14 2017-03-15 厦门绿洲安源投资管理有限公司 作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
ES2646271T3 (es) 2013-06-05 2017-12-13 Tricida Inc. Polímeros de unión de protones para la administración oral
LT3229816T (lt) 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
EP3270933B1 (en) 2015-03-20 2020-08-19 Howard University Polysaccharide-polyamine copolymers for removal of phosphate
US10723809B2 (en) 2015-03-20 2020-07-28 Howard University Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
WO2017153986A1 (en) 2016-03-08 2017-09-14 Technion Research & Development Foundation Limited Disinfection and removal of nitrogen species from saline aquaculture systems
MA44875A (fr) 2016-05-06 2019-03-13 Tricida Inc Compositions pour le traitement de troubles acido-basiques
MX2019007904A (es) 2016-12-28 2019-09-09 Fujifilm Corp Emulsion de polimero que contiene atomo de nitrogeno o la sal del mismo, metodo de produccion para el mismo y metodo de produccion para las particulas.
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2019078197A1 (ja) * 2017-10-16 2019-04-25 富士フイルム株式会社 高リン血症治療剤
TW201922268A (zh) * 2017-10-16 2019-06-16 日商富士軟片股份有限公司 高磷血症治療劑及粒子
US10479865B2 (en) 2017-11-01 2019-11-19 Strides Shasun Limited Process for the preparation of sevelamer carbonate
AU2018360867A1 (en) * 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
CN112047854B (zh) * 2020-10-20 2021-07-02 中国科学院长春应用化学研究所 一种n-乙烯基烷基酰胺的制备方法
EP4295836A1 (en) 2022-06-22 2023-12-27 Labomed Pharmaceutical Company S.A. Sachet comprising a liquid suspension of a sevelamer salt
WO2024084076A1 (en) * 2022-10-20 2024-04-25 Universiteit Gent Method to prepare amidated polymers

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE580490A (fr) * 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3332841A (en) * 1961-10-04 1967-07-25 Lilly Co Eli Method of treating hyperacidity
DE1927336A1 (de) * 1968-06-17 1969-12-18 Upjohn Co Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
CH604722A5 (xx) * 1973-02-09 1978-09-15 Sandoz Ag
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
AR206115A1 (es) * 1973-06-11 1976-06-30 Merck & Co Inc Procedimiento para preparar un polimero lineal no ramificado y no reticulado
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof
US4181718A (en) * 1975-12-29 1980-01-01 Mason Norbert S Polyanion-stabilized aluminum hydrogels
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
DE2741323A1 (de) * 1977-03-10 1978-09-14 Werner Klaus Konzack Raederfahrzeug
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS5566513A (en) * 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
US4247393A (en) * 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
ATE12511T1 (de) * 1980-12-12 1985-04-15 Smith & Nephew Ass Polymere, deren herstellung und verwendungen.
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
OA08092A (fr) * 1984-05-11 1987-03-31 Bristol Myers Co Novel bile sequestrant resin and uses.
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
JPS62132830A (ja) * 1985-12-05 1987-06-16 Teijin Ltd 徐放性医薬品組成物
DE68913602T2 (de) * 1988-07-13 1994-06-16 Collaborative Biomed Prod Gewebe-Immobilisierungs- und Zellkultursystem und Verfahren zum Anbringen biologisch wirksamer Teile an einem Substrat.
DE68911146T2 (de) * 1988-08-26 1994-04-14 Upjohn Co Feinkörniges colestipol hydrochlorid.
GB8829835D0 (en) * 1988-12-21 1989-02-15 Smith Kline French Lab Compounds
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
JPH0424180A (ja) * 1990-05-16 1992-01-28 Daikin Ind Ltd クローラ式小型運搬機
AU659106B2 (en) * 1990-11-06 1995-05-11 Fgn, Inc. Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates
IE914179A1 (en) * 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
JP2785529B2 (ja) * 1991-08-21 1998-08-13 日東紡績株式会社 エタノール徐放剤およびそれを用いた食品保存用組成物
EP0534304A1 (de) * 1991-09-21 1993-03-31 Hoechst Aktiengesellschaft Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
AU3592693A (en) * 1992-01-21 1993-08-03 University Of Utah, The Method and composition for heparin binding using polyaminocations covalently immobilised on polymeric surfaces with polyethylene oxide spacers
WO1993022380A1 (en) * 1992-05-06 1993-11-11 Isp Investments Inc. Polymers of vinyl-pyrrolidone and aminoalkyl acrylamides
DE4227019A1 (de) * 1992-08-14 1994-02-17 Geckeler Kurt E Priv Doz Dr Herstellung und Modifikation von Materialien auf der Basis von Amino- oder Amidpolymeren
US5633344A (en) * 1992-08-20 1997-05-27 E. I. Du Pont De Nemours & Company Crosslinked polymeric ammonium salts
US5302531A (en) * 1992-10-22 1994-04-12 Miles Inc. Composition for the semiquantitative determination of specific gravity of a test sample
DE69410995T2 (de) * 1993-02-17 1998-11-05 British Technology Group Ltd., London 1 guanidino gruppen enthaltende polymere zur verwendung in der therapie
WO1994027620A1 (en) * 1993-06-02 1994-12-08 Geltex Pharmaceuticals, Inc. Compositions and process for removing bile salts

Also Published As

Publication number Publication date
AU7560794A (en) 1995-03-14
CA2402590A1 (en) 1995-02-23
CA2169356A1 (en) 1995-02-23
DE69434726D1 (de) 2006-06-08
EP1676581A3 (en) 2008-12-03
DE69428122T2 (de) 2002-04-18
NZ271826A (en) 2000-06-23
KR960703607A (ko) 1996-08-31
DK0716606T3 (da) 2001-12-17
DE122009000081I1 (de) 2010-04-29
WO1995005184A2 (en) 1995-02-23
LU90884I2 (en) 2002-03-25
DE69428122D1 (de) 2001-10-04
DE69434726T2 (de) 2007-01-18
DE10299003I2 (de) 2006-07-13
AU689797B2 (en) 1998-04-09
ATE204756T1 (de) 2001-09-15
EP1133989A3 (en) 2004-05-12
WO1995005184A3 (en) 1995-03-23
NL300080I1 (nl) 2002-04-02
US5496545A (en) 1996-03-05
CA2169356C (en) 2000-07-04
DK1133989T3 (da) 2006-09-11
EP0716606A1 (en) 1996-06-19
EP0716606B1 (en) 2001-08-29
JP3113283B2 (ja) 2000-11-27
PT1133989E (pt) 2006-08-31
CA2310960A1 (en) 1995-02-23
EP0716606A4 (en) 1999-12-22
ES2260154T3 (es) 2006-11-01
NL300428I1 (nl) 2010-02-01
HK1009243A1 (en) 1999-05-28
LU91629I2 (fr) 2011-08-25
EP1676581A2 (en) 2006-07-05
JPH09504782A (ja) 1997-05-13
CA2310960C (en) 2003-05-27
ATE324900T1 (de) 2006-06-15
DE10299003I1 (de) 2002-05-08
PT716606E (pt) 2002-02-28
JP2001055336A (ja) 2001-02-27
EP1133989B1 (en) 2006-05-03
EP1133989A2 (en) 2001-09-19
KR100346766B1 (ko) 2003-10-04
ES2161780T3 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
HK1036753A1 (en) Polymer compositions for use in therapy
WO1996039156A3 (en) Phosphate-binding polymers for oral administration
EP0699072A4 (en) IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION
WO2005041900A3 (en) Polyamine polymers
CA2163361A1 (en) Therapeutic substituted guanidines
HUP0101189A2 (hu) Vas-dextrán vegyület felhasználása vashiány megelőzésére és kezelésére szolgáló gyógyszerkészítmény alkotórészeként, eljárás a nevezett vas-dextrán vegyület előállítására, és a nevezett vegyület felhasználása parenterálisan beadható gyógyszerkészítmény...
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
NZ330944A (en) Peptide derivatives
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
AU5922594A (en) Condensed quinolyl-dihydropyridines, processes for their preparation and their use in medicaments
CA2255913A1 (en) The use of buckminsterfullerene for treatment of neurotoxic injury
EP0585371A4 (en) Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
WO2001030334A3 (en) 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation
MY114084A (en) Phosphate - binding polymers for oral administration
MX9705305A (es) Polimeros fijadores de fosfato para administracion oral.
TR199701605A2 (xx) S�lfonamid-substit�e edilmi� bile�ikler
CA2239420A1 (en) Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
CA2239422A1 (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
ES2094093A1 (es) Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.
MY116727A (en) Tetrahydropyrido compounds

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20140809